Leprosy

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 29

Leprosy reactions: diagnosis and

management
Two types of reactions

 Type 1 or reversal reaction


 Cell-mediated immunity
 Local signs
 Long duration
 Type 2 or ENL reaction
 Humoral immunity
 Systemic signs
 Short episodes, but often chronic recurrence.
Severity

Mild Severe
 Red raised skin plaques  Ulcerating skin lesions
 Red, tender  Painful or tender nerves
subcutaneous nodules  Recent ( 6 mts) NFI
 Enlarged, non-tender  Reaction lesions in the
nerves face
 Severe oedema
 Involvement of other
organs.
Type 1 Reaction
(1)
Type 1 Reaction
(2)
Type 1 Reaction (3)
Type 1 Reaction (4)
Type 1 Reaction (5)
Type 1 Reaction (6)
Type 1 Reaction (7)
ENL Reaction (1)
ENL Reaction (2)
ENL Reaction (3)
ENL Reaction (4)
ENL Reaction: Iritis
Making the diagnosis

 History
 Physical examination
 Skin signs
 Nerve palpation
 NFA – sensory or motor impairment?
 Systemic signs (edema, fever, other organs)
 Criteria for sensory and motor impairment
 Criteria for reaction and severe neuritis.
Management of nerve damage

 Medical
 Surgical
 Supportive.
Medical management

 NFI ‘recent’ or ‘old’


 Corticosteroids – prednisolone
 WHO recommends 12-week course
 Evidence suggests longer course is needed
for MB patients (24 weeks)
 High-dose clofazimine in ENL
 Thalidomide drug of choice for ENL in men.
Prednisolone regimens

 Adults
 PB: starting dose 40 mg daily, duration 12 weeks
 MB: starting dose 40 mg daily, duration 24 weeks

 Children
 30 mg daily for one week, then alternate days,
tapering as above (12 weeks).
Patients over 15 years

PB: MB:
 40 mg od for 2 weeks  40 mg od for 4 weeks
 30 mg od for 2 weeks  30 mg od for 4 weeks
 20 mg od for 2 weeks  20 mg od for 4 weeks
 15 mg od for 2 weeks  15 mg od for 4 weeks
 10 mg od for 2 weeks  10 mg od for 4 weeks
 5 mg od for 2 weeks  5 mg od for 4 weeks
 Total: 16 weeks  Total: 24 weeks
Children up to 15

 30 mg od for 1 week
 30 mg alternate days for 1 week
 25 mg alternate days for 2 weeks
 20 mg alternate days for 2 weeks
 15 mg alternate days for 2 weeks
 10 mg alternate days for 2 weeks
 5 mg alternate days for 2 weeks
 Total: 12 weeks
Contraindications
 Acute or chronic untreated bacterial or parasitic
infection, e.g.
 TB
 Corneal ulcer
 Worm infestation
 Scabies
 Fungal infection
 Current peptic ulcer or recent history of
haematemesis or melaena
 Past history of psychosis or endogenous depression.
Relative contraindications

 Age under 15 or over 60


 Diabetes mellitus
 Hypertension
 Glaucoma
 Pregnancy
 Lack of cooperation
 Mature cataract
 Suspected peptic ulcer
Steroid side effects – major

Side effect Cases (401) Controls (414)


Diabetes 0.7% 0.2%

Peptic ulcer 0.5% 0.2%

Infections 0.7% 1.2%

Psychosis 0 0

Glaucoma 0 0

TB 0 0

Richardus et al., TRIPOD trials


Steroid side effects – minor

Side effect Cases (401) Controls (414)


Moon face 3% 2%

Acne 2% 0.7%

Fungal infections 1% 0

Gastric pain 18% 12%

Richardus et al., TRIPOD trials


Surgical management

 Different neurolysis techniques available


 Indications
 Nerve pain not responding to steroids
 Nerve abscess
 NFI not responding to steroids
 Benefit to be established through controlled
trial.
Neurolysis
Supportive management

 Analgesics – not aspirin or other NSAIDs


 Splinting
 Rest.
Comments and Questions.

You might also like